PEGylated Hyaluronic AcidModified Liposomal Delivery System with AntiGlutamylcyclotransferase

  • Slides: 8
Download presentation
PEGylated Hyaluronic Acid-Modified Liposomal Delivery System with Anti-γGlutamylcyclotransferase si. RNA for Drug-Resistant MCF-7 Breast

PEGylated Hyaluronic Acid-Modified Liposomal Delivery System with Anti-γGlutamylcyclotransferase si. RNA for Drug-Resistant MCF-7 Breast Cancer Therapy Rui Ran, Yayuan Liu, Huile Gao, Qifang Kuang, Qianyu Zhang, Jie Tang, Han Fu, Zhirong Zhang, Qin He JPharm. Sci Volume 104 Issue 2 Pages 476 -484 (February 2015) DOI: 10. 1002/jps. 24163 Copyright © 2014 Wiley Periodicals, Inc. and the American Pharmacists Association Terms and Conditions

Figure 1 JPharm. Sci 2015 104476 -484 DOI: (10. 1002/jps. 24163) Copyright © 2014

Figure 1 JPharm. Sci 2015 104476 -484 DOI: (10. 1002/jps. 24163) Copyright © 2014 Wiley Periodicals, Inc. and the American Pharmacists Association Terms and Conditions

Figure 2 JPharm. Sci 2015 104476 -484 DOI: (10. 1002/jps. 24163) Copyright © 2014

Figure 2 JPharm. Sci 2015 104476 -484 DOI: (10. 1002/jps. 24163) Copyright © 2014 Wiley Periodicals, Inc. and the American Pharmacists Association Terms and Conditions

Figure 3 JPharm. Sci 2015 104476 -484 DOI: (10. 1002/jps. 24163) Copyright © 2014

Figure 3 JPharm. Sci 2015 104476 -484 DOI: (10. 1002/jps. 24163) Copyright © 2014 Wiley Periodicals, Inc. and the American Pharmacists Association Terms and Conditions

Figure 4 JPharm. Sci 2015 104476 -484 DOI: (10. 1002/jps. 24163) Copyright © 2014

Figure 4 JPharm. Sci 2015 104476 -484 DOI: (10. 1002/jps. 24163) Copyright © 2014 Wiley Periodicals, Inc. and the American Pharmacists Association Terms and Conditions

Figure 5 JPharm. Sci 2015 104476 -484 DOI: (10. 1002/jps. 24163) Copyright © 2014

Figure 5 JPharm. Sci 2015 104476 -484 DOI: (10. 1002/jps. 24163) Copyright © 2014 Wiley Periodicals, Inc. and the American Pharmacists Association Terms and Conditions

Figure 6 JPharm. Sci 2015 104476 -484 DOI: (10. 1002/jps. 24163) Copyright © 2014

Figure 6 JPharm. Sci 2015 104476 -484 DOI: (10. 1002/jps. 24163) Copyright © 2014 Wiley Periodicals, Inc. and the American Pharmacists Association Terms and Conditions

Scheme 1 JPharm. Sci 2015 104476 -484 DOI: (10. 1002/jps. 24163) Copyright © 2014

Scheme 1 JPharm. Sci 2015 104476 -484 DOI: (10. 1002/jps. 24163) Copyright © 2014 Wiley Periodicals, Inc. and the American Pharmacists Association Terms and Conditions

Pegylated liposomal doxorubicin for the treatment of KaposisPegylated liposomal doxorubicin for the treatment of Kaposis
A randomized study of pegylated liposomal doxorubicin versusA randomized study of pegylated liposomal doxorubicin versus
Trabectedin plus pegylated liposomal doxorubicin in relapsed ovarianTrabectedin plus pegylated liposomal doxorubicin in relapsed ovarian
CALYPSO Trial Carboplatin Pegylated Liposomal Doxorubicin PLD versusCALYPSO Trial Carboplatin Pegylated Liposomal Doxorubicin PLD versus
Liposomal mucosal vaccine delivery system immunogenicity inflammatory responseLiposomal mucosal vaccine delivery system immunogenicity inflammatory response
Challenges facing liposomal delivery of vancomycin for combatingChallenges facing liposomal delivery of vancomycin for combating
Informed Delivery Informed Delivery AGENDA Informed Delivery PresentationInformed Delivery Informed Delivery AGENDA Informed Delivery Presentation